Table 4.
Controls No. (%) | Cases No. (%) | OR (95% CI) | p-Valuea | |
---|---|---|---|---|
p,p′-DDE | ||||
Low | 31 (41) | 38 (29) | 1.00 | 0.19 |
Medium | 21 (28) | 49 (37) | 2.17 (1.03–4.54) | |
High | 24 (32) | 45 (34) | 1.60 (0.79–3.25) | |
p,p′-DDT | ||||
Low | 25 (33) | 44 (33) | 1.00 | 0.12 |
Medium | 18 (24) | 52 (39) | 1.58 (0.74–3.36) | |
High | 33 (43) | 36 (27) | 0.56 (0.27–1.17) | |
HCB | ||||
Low | 29 (38) | 40 (30) | 1.00 | 0.23 |
Medium | 22 (29) | 47 (36) | 1.72 (0.83–3.54) | |
High | 25 (33) | 45 (34) | 1.60 (0.62–4.15) | |
α-HCH | ||||
Low | 33 (43) | 48 (36) | 1.00 | 0.081 |
Medium | 27 (36) | 37 (28) | 0.99 (0.49–1.98) | |
High | 16 (21) | 47 (36) | 2.02 (0.95–4.29) | |
β-HCH | ||||
Low | 26 (34) | 44 (33) | 1.00 | 0.81 |
Medium | 23 (30) | 45 (34) | 1.14 (0.55–2.36) | |
High | 27 (36) | 43 (33) | 0.88 (0.39–2.02) | |
γ-HCH | ||||
< LOD | 30 (39) | 61 (46) | 1.00 | 0.28 |
Medium | 22 (29) | 36 (27) | 0.79 (0.38–1.61) | |
High | 24 (32) | 35 (27) | 0.69 (0.34–1.38) | |
PCB-28 | ||||
< LOD | 65 (86) | 91 (69) | 1.00 | 0.006 |
> LOD | 11 (14) | 41 (31) | 2.75 (1.29–5.83) | |
PCB-118 | ||||
< LOD | 36 (47) | 43 (33) | 1.00 | 0.045 |
Medium | 20 (26) | 39 (30) | 1.63 (0.80–3.31) | |
High | 20 (26) | 50 (38) | 2.02 (1.00–4.08) | |
PCB-52 | ||||
< LOD | 69 (91) | 120 (91) | 1.00 | 0.77 |
> LOD | 7 (9) | 12 (9) | 1.16 (0.42–3.19) | |
PCB-153 | ||||
Low | 30 (39) | 39 (30) | 1.00 | 0.57 |
Medium | 22 (29) | 48 (36) | 1.50 (0.74–3.07) | |
High | 24 (32) | 45 (34) | 1.22 (0.59–2.52) | |
PCB-138 | ||||
Low | 26 (34) | 43 (33) | 1.00 | 0.79 |
Medium | 26 (34) | 44 (33) | 0.85 (0.41–1.75) | |
High | 24 (32) | 45 (34) | 0.90 (0.43–1.90) | |
PCB-180 | ||||
Low | 29 (38) | 41 (31) | 1.00 | 0.63 |
Medium | 24 (32) | 44 (33) | 1.20 (0.59–2.42) | |
High | 23 (30) | 47 (36) | 1.19 (0.57–2.49) |
p-Value for trend adjusted for age, sex, energy intake, and BMI.